PLACENTAL ABRUPTION: MATERNAL-FETAL OUTCOMES AT A HOSPITAL IN WESTERN PARANÁ

Abstract

This article aimed to analyze the clinical and obstetric profiles, as well as maternal and neonatal outcomes, of patients diagnosed with placental abruption who underwent cesarean section at a tertiary hospital. This was a retrospective observational study based on the analysis of medical records of patients diagnosed with placental abruption between 2022 and 2025. Sociodemographic characteristics, obstetric history, clinical manifestations, laboratory tests, ultrasound findings, and maternal and neonatal outcomes were evaluated. Twenty patients were included, with a mean age of 28.45 years; the majority were multigravid (60%) and white (80%). The main comorbidities observed were hypertensive disorders of pregnancy, thrombophilia associated with antiphospholipid syndrome, and gestational diabetes mellitus. The most frequent clinical manifestations were vaginal bleeding (85%) and abdominal pain (80%), while the classic triad of placental abruption was identified in only 10% of cases. Regarding neonatal outcomes, prematurity was observed in 65% of newborns, and 55% required admission to the Neonatal Intensive Care Unit. It is concluded that placental abruption remains associated with high maternal and neonatal morbidity, highlighting the importance of early diagnosis and immediate obstetric intervention to minimize maternal-fetal complications.